by Erika K Wolf | Jul 24, 2026 | Alloimmune Thrombocytopenia, Blogs, Condition, Fetal Thrombocytopenia, fetomaternal alloimmunization, FNAIT, front-page, HDFN, Hemolytic Disease, News, Rh Disease, Story
For families facing a pregnancy complicated by rare alloimmune conditions, access to specialized care and innovative research can make all the difference. The University of Texas Medical Branch (UTMB) is helping lead that effort as an active study site for two...
by Erika K Wolf | Aug 6, 2024 | Alloimmune Thrombocytopenia, Blogs, front-page, HDFN, Hemolytic Disease, News, Rh Disease, Story, Uncategorized
2-minute read
HDFN is a rare fetal syndrome that affects later pregnancies. Johnson & Johnson is pioneering research to help women at severe risk. Their clinical trial is currently enrolling women who are at risk for severe HDFN who have a history of severe HDFN in a prior pregnancy.
